LOIP
IDXX icon

Live Oak Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Live Oak Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
2,478
+176
+8% +$98.7K 0.7% 39
2026
Q1 		$1.29M Buy
2,302
+198
+9% +$127K 0.76% 37
2025
Q4 		$1.42M Buy
2,104
+508
+32% +$346K 0.87% 35
2025
Q3 		$1.02M Buy
1,596
+232
+17% +$141K 0.68% 37
2025
Q2 		$732K Buy
+1,364
New +$652K 0.56% 48

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Live Oak Investment Partners's IDXX Position: Q2 2026 in Review

Live Oak Investment Partners increased its Idexx Laboratories (IDXX) stake by 7.6% in Q2 2026, buying an estimated $98.7K and bringing the position to 2,478 shares worth $1.3M. The position accounts for 0.7% of the portfolio, ranked #39.

Live Oak Investment Partners first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.42M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Live Oak Investment Partners held 2,478 shares of Idexx Laboratories worth $1.3M as of Q2 2026.
  • Live Oak Investment Partners bought 176 Idexx Laboratories shares in Q2 2026, an estimated $98.7K.
  • Idexx Laboratories made up 0.7% of Live Oak Investment Partners's portfolio in Q2 2026, its #39 holding.
  • Live Oak Investment Partners first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Live Oak Investment Partners's Idexx Laboratories position peaked at $1.42M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Live Oak Investment Partners's 13F filing for Q2 2026, filed 10 Aug 2026.